Aprepitant for severe refractory pruritus in a patient with relapsed Hodgkin lymphoma

Pediatr Blood Cancer. 2024 Mar;71(3):e30826. doi: 10.1002/pbc.30826. Epub 2023 Dec 25.

Authors

Anwar Al Nassan¹, Faiha Bazzeh^{1

2}, Iyad Sultan^{1

2

3}

Affiliations

¹ Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan.
² Department of Pediatrics, Jordan University Hospital, Amman, Jordan.
³ Artificial Intelligence and Data Innovation Office, King Hussein Cancer Center, Amman, Jordan.

PMID: 38146019
DOI: 10.1002/pbc.30826

No abstract available

Publication types

Letter

MeSH terms

Aprepitant
Hodgkin Disease* / complications
Hodgkin Disease* / drug therapy
Hodgkin Disease* / pathology
Humans
Morpholines / therapeutic use
Patients
Pruritus / drug therapy
Pruritus / etiology
Pruritus / pathology

Substances

Aprepitant
Morpholines